Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

33.09

-1.06 (-3.10%)

At close: Dec 11, 2025, 4:00 PM EST

31.90

-1.19 (-3.60%)

After-hours: Dec 11, 2025, 7:05 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.